Not applicableLooking for participantsNCT00903110
What this trial is testing
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Who this might be right for
IGF1 Deficiency
Esteve Pharmaceuticals, S.A. 500